Home Pharmaceutical
Pharmaceutical Market Research Reports
Published Date: 2013-05-06
The cell culture market is experiencing impressive growth globally because of the tremendous increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life science industry, the cell culture market has experienced huge growth in terms of scope as well as adoption by end users. The rapid double-digit growth in biotechnology and biopharmaceutical industries is slated to be the major driving force for the growth of the cell culture market in the future.
Published Date: 2013-04-22
The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth as compared to conventional seeds over the forecast period.
Published Date: 2013-03-20
This report provides an in-depth analysis and market forecast for the global pharmacy automation market for the period 2012 – 2018. The report provides details of the several pharmacy automation devices currently available in the market along with the impact of these machines on modern pharmacies in terms of efficiency, reduction in error and speed.
Published Date: 2013-03-13
Peptide therapeutics is evolving as a promising field over the past few years as a result of continuous research and developments in the field for developing new and effective drugs. New delivery techniques and manufacturing technologies coupled with intensified research and development programs is resulting in the approval of new peptide based drugs.Peptide therapeutics is the best option in recombinant medicines due to their low toxicity, high specificity, and much lower molecular weight which makes it easier to prepare dosage plans for patients. Improvements in manufacturing process and delivery systems are triggering the growth of this industry.
Published Date: 2013-02-20
Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations.
Published Date: 2013-01-24
This report provides the market estimate and forecast in terms of revenue for the global cloud computing market in healthcare industry. A detailed analysis of the market trends, current scenarios and future trends from 2012 to 2018 is available in the report. The market is analyzed by using concepts such as market dynamics including drivers, restraints and opportunities along with their impact analysis and market attractiveness analysis.
Published Date: 2013-01-17
This report covers the market revenue for the global healthcare contract research outsourcing market. A detailed analysis of the market trends, current scenarios and future trends is available in the report. The market is analyzed by using concepts such as market dynamics including drivers, restraints and opportunities along with their impact analyses trend analysis, and market attractiveness analysis.
Published Date: 2013-01-16
This report covers the performance of the various drugs class segment used in liver disease therapeutics in terms of their revenue. The global market for liver diseases therapeutics is classified into seven drug class segments namely, anti-viral drugs, vaccines, immunosuppressants, immunoglobulins, targeted therapy, corticosteroids and chemotherapy with their estimated and forecasted market size from 2012 to 2018, along with their compound annual growth rate.Published Date: 2013-01-07
General Medicine or internal medicine is a branch of medicine which deals with the prevention, diagnosis and subsequent treatment of adult diseases. The specialists who deal with this branch of medicine are called “internists” and ones who work with children are called pediatricians. General Medicine is further specialized depending on the organ or organ systems, such as cardiology, anesthesiology, endocrinology, nephrology etc. On an average 75,000 medical students choose internal medicine as a career option annually around the world.
Published Date: 2012-11-28
Global market for bioinformatics is expected to reach $8.3 billion over the year 2014 at the CAGR of 24.8% during the forecasted period. With the increasing demands from US and Europe, among all major segments bioinformatics platforms market is expected to have the maximum share. Developing economies like US and Europe are biggest consumers of this market and this trend is supported by increasing demand for sequencing platforms with growing research in the field of life sciences using the techniques like gene expression analysis, protein expression analysis, and sequence analysis.
Published Date: 2012-11-28
This report is an effort to identify factors, which will be the driving force behind the market penetration and corresponding sales of the pipeline chemotherapy-induced nausea and vomiting (CINV) drugs, namely the combination drug netupitant–palonosetron FDC (fixed-dose combination), APF530 and rolapitant, in the next seven years.Published Date: 2012-11-25
In this research report Transparency Market Research analyzes the global high-potency active pharmaceutical ingredients market (HPAPI) along with market dynamics and present market condition. It also covers the market of high-potency active pharmaceutical ingredients types and application in different regions of the world namely, North America, Europe, Asia and RoW along with their sub segments.
Published Date: 2012-10-30
Neuromodulation is one of the fastest growing sectors in the medical devices market. Neuromodulation devices provide symptomatic relief through alteration, or modulation of nerve system function. Neuromodulation functions either by stimulating nerves to produce a natural biological response or by applying small doses of medicines directly to the site of action. The neuromodulation devices market is growing rapidly due to increase in the ageing population resulting in increased demand for newer treatment options for age related diseases. This market is expected to benefit from the rise in demand for non-invasive treatment options.
Published Date: 2012-10-29
Increasing incidences of genetic diseases and rising rate of infertility are giving rise to diagnostic procedures like preimplantation genetic diagnosis. Preimplantation genetic diagnosis market is at its early stage and hence opening up new opportunities for expansion of this industry with continuous developments and emergence of new players. This virtually untapped market harbors numerous targets for strategic achievement and provides new applications for advanced genomic technologies. Increasing number of services in preimplantation genetic diagnosis (PGD) industry will attract more number of patients, thus boosting the industry growth. Market characteristics of PGD industry are dictated by dynamics of infertility markets. The greater market saturation achieved by expanding PGD services will promote the overall growth of this market in the future.Published Date: 2012-10-26
This report covers an analysis for cervical cancer diagnostic tests (Pap smear tests, Colposcopy tests and ECC procedures) market. The market is analyzed in terms of number of test results and procedures performed in thousands and revenue in USD thousands. Pap smear testing is a cervical cancer diagnosis method performed on women. It is a preventive measure and is done to test for the presence of cervical cancer in an early stage. Cervical cancer, if detected at an early stage could be treated successfully. An abnormal Pap smear test result leads to the performance of further tests and procedures in order to confirm the presence of cervical cancer.
Published Date: 2012-10-24
This report covers Netupitant - Palonosetron FDC along with their sales projection, current scenario, SWOT analysis, clinical trials and opportunities. It also covers the factors driving this market and the regional analysis including United States, Europe, Australia and UK among others. The present market condition and performance has been mentioned in detail along with the CINV patient pool.Published Date: 2012-09-19
This report is an effort to identify factors, which will be the driving force behind the Insulin market in each of the country analyzed based on sub-segments, types of diabetes, value chain and market types over the next five years. The report provides extensive analysis of the Insulin market, current market trends and future forecast for better understanding of the Individual Insulin market.Published Date: 2012-09-13
This report helps to identify factors, which will be the driving force behind the U.S. vaccine market and sub-markets in the next six years. The report provides extensive analysis of the US vaccine industry, current market trends, industry drivers and challenges for better understanding of the U.S.vaccine market structure. The report has segregated the U.S. vaccine industry in terms of product type.Published Date: 2012-08-21
The global market for synthetic biology is estimated to grow to $4.5 billion over the year 2015 owing to the developments in fields like biomedicine, biopharmaceutical synthesis, energy and environment, biosecurity, sustainable chemical segment, and biomaterials. Significant investments by major companies and emergence of new players in the market are also expected to boost the growth of this industry.Synthetic biology is the fastest growing segment of the biotechnology field having number of applications. Synthetic biology provides significant number of near future commercial opportunities. Despite its emerging status, the list of applications is continuously growing. Some of these major applications include chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms among others.Published Date: 2012-08-15
Circulating tumor cell technology is an enabling technology for recovery and analysis of separated cancer cells in the peripheral blood. CTC technology offers advantages like high sensitivity, high specificity, reproducible, repeatable, and non-invasive diagnostic assay for guiding treatment decision and improved patient triage.
Published Date: 2012-06-18
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are diseases that cause chest symptoms leading to coughing, difficulty in breathing and wheezing. Asthma impacts a patient during the night time whereas COPD affects the patient during the day time. They can coexist in the same individual whereas the cause and treatment of both these symptoms are different. Asthma is caused majorly due to allergies whereas COPD is a result of smoking. Asthma leads to inflammation of lungs and COPD leads to destructive illness of lungs.
Published Date: 2012-04-16
This report analyzes the worldwide markets for Nutraceutical Ingredient in USD million by the following segments: body building, weight control, controlling diabetes, and pain relief. The report provides separate comprehensive analytics for the North America, Western Europe, Eastern Europe, Asia Pacific, Latin America and MEA. Annual estimates and forecasts are provided for the period 2012 through 2017. Also, a five-year historic analysis is provided for these markets.
Published Date: 2012-03-21
The global market of nutraceutical is a growing on account of growth in dietary supplement segment. North America has the highest market share for nutraceutical product market.
Published Date: 2012-02-21
Functional beverages are the largest segment of Western Europe nutraceuticals market accounting for about 44.5% market revenue in 2011. Functional beverages were the fastest growing market of Western Europe nutraceuticals market during 2007 – 2011 with a CAGR of 6.6%.
Published Date: 2012-02-20
Russia is the largest consumer of nutraceuticals in the region. The growth in nutraceutical products taking place due to increasing made age population in the region.
Published Date: 2012-02-20
The Middle East and Africa (MEA) Nutraceutical product market had the highest growth rate during the evaluation period (2007 – 2011). The market grew with a CAGR of 8.7% during 2007 – 2011 to attain a market size of USD 2.5 billion in 2011.
Published Date: 2012-02-20
Brazil has highest market share of nutraceuticals product in Latin American region. The Latin America nutraceuticals market reached USD 7.8 billion in 2011 from USD 6.6 billion in 2007 with CAGR of 4.2% during 2007 – 2011.Published Date: 2012-02-20
The North America Nutraceutical product market is relatively matured market. The U.S. the largest consumers of nutraceuticals product as people are more conscious about their health, physical fitness and mental well-being.
Published Date: 2012-02-16
The Asia Pacific nutraceuticals product market is growing on account of the growth in dietary supplements and functional food segments. Asia – Pacific nutraceuticals dietary supplement market will have high growth rate during the forecast period (from 2012 to 2017).
Published Date: 2012-01-30
In 2009, the global Osteoporosis drug market was worth USD 6.8 billion, with Bisphosphonate class of drugs leading the market. Amgen’s Denosumab is the recent entrant to the Osteoporosis treatment market, following its approval from the U.S. and European Union (also approved for bone loss associated with prostate cancer).
Published Date: 2012-01-16
Increased prevalence of Osteoporosis among Chinese female population is the principal growth driver of the Osteoporosis drug industry. The other key growth drivers for Chinese Osteoporosis market include increasing elderly aged population, rising living standards of the Chinese people and increasing awareness and bone health education.Upcoming Market Research Reports in Pharmaceutical
Orphan drugs are specific pharmaceutical agents which are developed for treatment of orphan or rare diseases. Orphan disease, according to laws of various countries, may include medical conditions which have low prevalence, i.e. affects less than 200,000 persons (U.S.), or 50,000 (Japan). Expiring patents of blockbuster drugs, drying pipelines, stringent regulations across the globe, has encouraged the pharmaceutical industries to shift the focus to a new business model that includes niche busters or orphan drugs.
Alzheimer’s disease is a neurological disorder of the brain which is progressive and ultimately leads to loss of neurons. This condition leads to loss of memory and reasoning abilities. Currently, there is no treatment for Alzheimer’s, although there are certain ways of slowing down its progression. Physicians generally prescribe neurotransmitters like cholinesterase inhibitors, memantine, etc.
Healthcare-associated infections (HAIs) are the ones that are contracted by patients while they are receiving treatment for another medical condition in a healthcare setting. Thus HAIs can be acquired at any place where healthcare is delivered. HAIs are generally caused by infectious agents, pathogens, fungi, bacteria, and viruses.
Autacoids are certain biological factors that act like hormones and help in treating local injuries and other ailments. Autacoids are temporarily formed in the body and act locally. They have many different actions such as modulation of action of glands, smooth muscles, platelets, nerves, and other tissues. They are released by stimuli and when they are released into the body, they can bring certain changes such as itching, skin reddening, and bronchospasms.
The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs.
Sexually transmitted diseases (STD), also known as venereal diseases have significant probability of transmission among humans by means of human sexual behavior. These diseases can also spread through childbirth or breast feeding and by the shared use of needles. Diseases such as HIV, HPV, and Hepatitis B & C are forms of STDs.
Depression is considered as one of the most common forms of psychiatric disorders. Depression is a disabling condition that not only affects the health and wellbeing of the patient but also adversely affects the family. Every year the prevalence of depression is rapidly increasing across the world. Anxiety is a reaction to stress. Normally, it is characterized as an urge to deal with adverse situations.
Molecular diagnostics, also called as MDx, is a branch of in vitro diagnostics that helps in identification of nucleic acids. Molecular diagnostics assist in identifying nucleic acids in foreign organisms or genetic markers of any patient. MDx tests is the fastest growing branch of in vitro diagnostics and its growth is influenced by factors such as rapid turnaround time, high sensitivity, low cost and convenient workflow.
Pulmonary arterial hypertension (PAH), a type of pulmonary hypertension results from high blood pressure associated with arteries of the lungs. In PAH, the arteries of the lungs (pulmonary arteries) become narrower than their actual size, giving rise to high blood pressure in the arteries of the lungs thus putting pressure on the right ventricle of the heart. Some of the main causes of occurrences of this disease are bad habits such as stressful lifestyle, intake of certain medicines etc.
Adjuvant oncology treatment comprises of a class of cancer therapeutics which is followed after primary cancer treatment, to minimize the risk of reoccurrence of cancer. The major forms of adjuvant therapy are radiation therapy, chemotherapy, hormone therapy, biological therapy, and targeted therapy. Before deciding the adjuvant therapy to be used, statistical evidence is used by oncologists for the assessment of risk of disease relapse.
Antipsychotics are drugs used in the treatment of brain disorders such as schizophrenia, bipolar disorder, and severe depression. According to the New York Times, antipsychotics are one of the largest types of prescribed drugs in the United States with over 3.1 million Americans accounting for a market worth USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders.
Life science and analytical reagents are those compounds and substances which are used to detect and create a new substance with the purpose of making them available for test reading and are also known as biotechnology reagents. Such reagents are significant in the areas of research, bioscience, diagnosis and education.
Development of enzymes in medical technology has been as extensive an application as that of its applications in other industrial sectors. There are a variety of enzymes that can be used in different therapeutics. At present, extracellular application of enzymes, which involves removal of toxic substances and treatment of disorders in blood circulation, has been found to be the most successful one in medical technology.
The market is expected to exhibit high growth in developed economies such as the U.S. and Europe over the forecast period. The rapid increase in the number of patients suffering from depression is expected to be one of the main driving forces for the estimated growth, which can be attributed to elevating stress levels, unhealthy lifestyle, and social imbalances.
Pain is an overall condition of sensory discomfort owing to some tissue damage. It could be classified as acute pain and chronic. Pain has always been one of the major reasons for patients seeking medical help. Every year about half a million people succumb to death owing to chronic pain. Certain analgesics are used as primary pain relievers in which they decrease the sodium and potassium levels in the neurons thus reducing the transmit of pain.
Antibodies and proteins developed with new and advantageous functions and properties are known as engineering of proteins and antibodies. Protein engineering can be defined as a process of developing valuable proteins and modification of antibodies to increase similarity and is called antibody engineering.
Musculoskeletal diseases/disorders (MSDs) are diseases of muscles and related ligaments, and other connective tissues and bones. Some of the most common musculoskeletal diseases are back pain, osteoarthritis, rheumatoid arthritis, osteoporosis, septic arthritis, gout, myasthenia gravis, systemic lupus erythematosus (SLE), and some others. Musculoskeletal diseases are the prime cause of short term disability and chronic disability in this generation.
The market is currently facing growth hindrances as R&D approaches, and regulatory and reimbursement policies are inconspicuous owing to the nascent nature of the market. However, regulatory bodies are working enthusiastically to lay out policies and growth strategies, due to the fact that it holds the potential to solve or curb chronic diseases, with no currently available treatments, such as HIV AIDS.
Prefilled syringes are primary injectable drug delivery devices administered by a medical practitioner or a healthcare provider. These syringes are prefilled with drugs with an appropriate and prescribed amount, and so are ready to be used by the patients directly. Currently, there are over 60 types of drug prefilled syringes available in the market and many more are in product pipelines.
Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can affect any part of the body. Symptoms include imbalance, loss of motor function, spasms, numbness, incontinence, and difficulty in swallowing.
Point of care (POC) diagnostics comprises of diagnostic tests that are performed at the patient site. POC diagnostics provides fast results which in turn help in faster patient management. The present POC diagnostics market already sports a number of products with several new products in the development stage.
Artificial tears are designed to imitate the real tears and for the enhancement of different eyes problems. These are eye drops specially used for the treatment caused due to irritation and dryness .artificial tears is made using polymers, water, and salts. These tears lack the proteins which are found in the real ones.
Multiple myeloma is a form of plasma cancer that develops in the bone marrow. It is the second most prevalent blood cancer type in the U.S. In 2011, the global multiple myeloma drugs market was calculated at USD 3.2 billion. The market will be driven by factors such as rising incidences of plasma cancer, and lifestyle habits.
The global Angiogenesis Inhibitors and Stimulators Market is growing with a healthy growth rate due to increase in incidences of heart disease and cancer, unmet need in current therapeutic scenario, and ageing population. Moreover, growing adoption of the approved Anti - Angiogenic drugs across diverse cancer therapeutic is also driving growth of Angiogenesis Inhibitors and Stimulators Market.
Some of the major factors which are driving the clinical diagnosis automation market include: growing number of diagnosis globally, low reimbursement rates and growing number of suppliers in the diagnostic market. Many players in the clinical diagnostics market, due to intense competition are looking to sustain in the market by gaining some competitive advantage over each other.
The testosterone replacement therapy is a process of giving testosterone when testes do not produce sufficient amount of testosterone because of injury, damage or absence. The testosterone replacement therapy has gained the momentum in last decade with high penetration in surgery market. The testosterone replacement therapy market could be segmented into 3 categories based on the type of product, into the following sub segments: gel, patches and other.
Bio-services involve preclinical and clinical researches done by following the standards laid down by regulatory bodies. Clinical research organizations (CRO) segment their researches by contracts, manufacturing, and clinical trials. A clinical trial is a time consuming process, and specifies testing of the new drugs on specific people or for particular diseases. CRO can be divided into captive and independent.
The branch of nanotechnology that deals with the study of biological and biochemical applications is known as nano-biotechnology. The study indulges mostly into deeply classifying the elements of living things or organisms and then modifying the same into nano products. Nano-biotechnology is a vital element boosting the new developments in the field of biotechnology. Biological research coupled with nano-technology continuously leads to the development of new inventions.
DNA Probes-based diagnostics deals with the study to examine the chemical structure of DNA by undoing the presence of abnormal gene sequence of DNA on the DNA strand. This abnormal gene sequence is mainly responsible for causing disease and hence technique such as gene polymorphism can help to limit the chances of occurrence of diseases.
The similarities in the structure and functioning of body parts in humans and in animals increases the size of the animal therapeutics and diagnostics market. The rising number of pet adoptions across the globe, rising incidences of chronic diseases such as bovine spongiform encephalopathy, rising global meat consumption, and the rising incidences of pet obesity, especially in developed countries such as the U.S., are some of the growth drivers for the market.
Collagen peptide is a protein which is a primary constituent of the fibrous connective tissue found in skin, bones, and cartilage. These proteins form the dermal layers below the skin to keep the skin firm and healthy. Collagen peptide is used in pharmaceutical, food, dietary supplements, and cosmetic industries. They have various application segments such as in sports performance, weight management, skin health, and joint and bone health.
Psoriatic Arthritis is a type of rheumatoid arthritis which mainly affects fingers and toes followed by psoriasis. Moreover, a condition in which person has both psoriasis and arthritis is identified to have suffered from psoriatic arthritis. Major symptom for psoriatic arthritis is associated with inflammation of the skin and joints. About 11% of patients who has psoriatic also develop inflammation of their joints in a time frame ranging from 6 months to 1 year or sometimes even more, depending upon the personality of the patient.
Occult blood testing is carried out to test for the presence of microscopic or invisible blood cells in the stool. It is a type of colorectal cancer screening test. Occult blood is the sign of a problem in the digestive system, which can be a polyp, growth, or a cancer in the rectum or colon. Once microscopic blood is detected, proper diagnosis can take place. Occult blood can also be the result of ulcerative colitis, Crohn’s disease, diverticular disease (caused by outpouching of the colon wall), and abnormalities of the blood vessel in the large intestine, etc.
More than 1.5 billion people around the world suffer from chronic pain and it is one of the leading causes of patients seeking medical care. Moreover, cost of pain comes to around USD 100 billion per year which includes lost workdays and medical bills. The global pain management therapeutics has observed healthy growth rate in the past and has huge market potential in the future due to increase in the number of population that suffers from medically significant pain.
Artificial joints have been anchored with bone cements for more than half a century. Bone cement plays the important role of an elastic zone by filling the space between the prosthesis and the bone. The necessity of bone cement is supported by the fact that the human hip is acted on by 10-12 times the body weight and therefore the forces acting on hips should be absorbed by the bone cement to ensure the safety of artificial implants.
The global pharmaceutical contract manufacturing (PCM) market is believed to hold huge opportunities in the future. With economic constraints in European countries, global pharma manufacturing companies are facing extensive cost containment pressures. As a result, pharmaceutical companies are compelled to explore ways to reduce the cost of drug manufacturing.
Uranium is mostly used in nuclear power plants to generate electricity. The rising demand for electricity and the capacity of nuclear reactors is driving the uranium market. The global uranium market is expected to witness significant growth in next six years. Nearly 75% of uranium supply is through mining activity and it is expected to grow further in the coming years.
Rising global prevalence of Parkinson’s disease, cardiovascular diseases and rapidly aging world’s population are some of the drivers for the blood-brain barrier technologies market. Blood-brain barriers create CNS drug delivery problems and manufacturers are making rigorous investments in research and development to invent new drugs and drug delivery systems to amend CNS drug delivery problems. This holds the potential to open up new avenues for the market in terms of future growth opportunities.
Liposomes are phospholipid vesicles used for drug delivery. Inhalation drug delivery technologies mainly deal with pulmonary drug delivery. Such technologies form a part of advanced drug delivery technologies. Rising prevalence of pulmonary disorders, frequent discovery of new drugs, and technological advancements in the field of healthcare and biotechnology are some of the growth drivers for the market. Economic growth in the Asian and Latin American region will serve as future growth opportunities for the market.
Isothermal nucleic acid amplification technology (INAAT) is the global scale study and development of testing and applications of nucleic acid in molecular and nanoparticle diagnostics and laboratory research.
Cancer cells exhibit a fundamentally modified metabolism that creates an environment in the body to support the growth of tumors and malignancy. In-depth understanding of the biochemical characters of cancer has facilitated the understanding and implementation of several different cancer profiling platforms.
A mental disorder is a psychological anomaly that is reflected in the behavior of the patient through distress, disability or any conduct that is not a part of a person’s normal mental development. The causes of mental disorders are varied in nature and many are also unclear. Psychiatric medication and psychotherapy are the two modes of treatment for mental disorder. In psychiatric medication drug classes such as antidepressants, anxiolytics, and antipsychotics are most commonly used.
Metabolomics is a nascent upcoming technology in the field of analytical biochemistry. It can be defined as a systematic study of unique chemical fingerprints that specific cellular processes leave behind. The metabolomics study engages study of metabolic profiles and their comparative analysis. The major hindrance profiling these metabolites is the analysis of all classes of compounds found in the organism and not a single entity like a cell, protein or DNA. Hence, to analyze such minutest details in the organism requires robust platforms.
A global surge of patient pool and healthcare professionals along with enhancement in medical technology has propelled the growth in the medical tourism market. Medical tourism is when the consumers opt to travel abroad to take advantage of some form of medical treatment at a more affordable price. Rise in the large number of uninsured population in developed countries like the U.S. and frail reimbursement policies has forced people in these regions to exploit cost effective methods of medical treatments.
Over 50% of the world’s most popular drugs are sourced directly or indirectly from natural sources. Pioneering research in marine based drug discovery began with Roche Research Institute of Marine Pharmacology during the mid 1970s. Tethya crypta a marine sponge was the first organism to be commercialized to produce drugs against HIV & Herpes. A small number of marine organisms primarily constituting of algae and other invertebrates have already been researched for commercial value in pharmaceuticals.
Fetal monitoring refers to the use of an instrument to record the pulse rate of a fetus during pregnancy. Post fetal monitoring discrepancies in the heartbeat of a fetus are observed and this monitoring data is later used for diagnostic purposes.
Fungal infections occur due to unhygienic, damp, and unclean environment. They are caused by microscopic organisms that can invade the epithelial tissue. Most dermal infections are the tinea group of infections and are commonly observed in people. They affect nails, hair, scalp, and the skin in various areas of the body.
Nanoscience or nanotechnology is the study of management of materials at molecular or atomic scale on different applications. The market for nanoparticles in drug technology holds prime share in the global pharmaceuticals market. Applications of nanotechnology can be classified into nanomedicine, chemicals and cosmetics, materials, food technology, energy, military, electronics, agriculture and others.
The drug delivery method plays a crucial part in the success of any drug. Drugs with high efficacy and those which are easy to use are an instant success in most medical communities and even among patients. Pulmonary drug delivery is the inhalation of aerosol based drugs through a device called “Inhaler” and the drug aerosol is called an inhalable.
Marine derived pharmaceuticals are the drugs and other pharmacological substances which are made from extracting elements present in marine life. Although the concept of marine ethnomedicine dates back to the 18th and 19th century, actual exploratory work on marine pharmacology began in the mid and late 1960s when groups of chemists in the United States, Japan, and Europe began to explore sponges, marine algae, and other forms of marine life for their medicinal properties.
The global arthroscopy market is expected to undergo rapid growth in the next few years. Arthroscopy is a minimally invasive orthopedic surgical procedure in which examination of joints and their treatment is performed. Arthroscopic procedures are thus primarily performed to evaluate or treat certain orthopedic conditions such as torn cartilage, ACL reconstruction and others.
Monoclonal antibodies have brought a paradigm shift in biotechnology and pharmaceutical sectors. Monoclonal antibodies (mAbs) are mono-specific antibodies which comprise of identical immune cells and these immune cells are clones of a single parent cell and are distinguished by their unique property to bind to the same epitope.
The term ‘cell based assay’ refers to the use of live cells to test the effect of a foreign substance on the functionalities and behavior of a cell. These cell based assays are the most accurate method of cell testing, due to the fact that live cells are utilized for experiments. It is used for determining factors like cell toxicity, cell proliferation, motility, and cell morphology. The global market for cell based assays is expected to reach an estimated value of USD 1.55 billion in 2018.
Drug discovery technologies play a significant role in the field of pharmaceuticals as they heavily contribute to the introduction of drugs to the market. The application of drug discovery technologies have a significant opportunity in the launch of drugs for severe diseases such as cancer, cardiovascular diseases, Parkinson’s disease, central nervous system disorders and others. However, the slow growth in the introduction of blockbuster drugs could pose a major threat for the growth of this market.
This market includes various products, technologies and services which are used in sample preparation for genomics, proteomics and epigenomics. The market was valued at USD 4 billion in 2011 and is expected to reach USD 9 billion by 2016, growing at a CAGR of 19%. This can be attributed to the fact that sample preparation is the basic step involved in any life sciences research project.
Biological therapies for cancer include the usage of body’s immune system to curb cancer and to fight the side effects generated out of some other chemotherapeutic treatments. The human body has biological response modifiers (BRMs) that stimulate the body’s response towards an infection. Scientists are now involved in producing such biological response modifiers artificially in laboratories to use them in triggering an immune response against cancer.
Antibody drugs make use of the body’s own immune system to locate and eliminate cells which are responsible for the target disease. Antibody drugs have been successful in attracting the attention of researchers worldwide owing to their characteristic features such as fewer side effects and high efficacy in curing certain diseases which were previously untreatable.
Neurodegenerative disorders cause progressive loss of function structure of the neurons in the human brain. The most commonly known neurodegenerative diseases are Alzheimer’s, Parkinson’s, Amyotrophic lateral sclerosis, and Huntington’s Syndrome. Most neurodegenerative disorders are caused because of genetic mutation in completely unrelated cells.
Polymerase chain reaction (PCR) is a simple and rapid method to amplify DNA, i.e. produce a large number of clones of DNA molecules from a sample. In the fields of molecular biology or molecular pathology, where the sample quality might be poor, PCR has become the most widely used technology.
Preventive healthcare technology refers to a very broad range of products and services used on a regular basis for diagnosis, monitoring, and control of diseases ranging from minor colds to major ailments such as breast cancer, heart attacks, and stroke etc. This broad range of devices can be used through a mobile platform and as independent technologies as well.
Kinase inhibitors are enzymes which selectively block the action of other enzymes. They help in regulation of the activity of other proteins and, more indirectly, the activities of cells. All these kinases can be divided by amino acids in which phosphorylation is inhibited. Since they can control or regulate the activities of other cells, they are often used in the treatment of cancer and inflammatory conditions.
Increasing focus on research and development initiatives by the drug manufacturers, lift of export standards for heparin and global aging population are the three most prominent growth drivers for the market. Rise in the healthcare expenditure and research in emerging economies especially China and the presence of a strong pipeline exploring new application areas for heparin, are some of the future growth opportunities for the market.
Theranostics is the fusion of drug therapy and diagnostics to optimize effectiveness, safety, and streamline drug development. Combination of medical drugs with diagnostic tests is also known as integrated medicine, pharmacodiagnostics, companion diagnostics, and Dx/Rx partnering. Theranostics market is an emerging field which is generating strong interest from healthcare industry and regulatory bodies. It is an emerging clinical diagnostics field that focuses on developing specific analysis to predict the use of most significant drug for patient.
Autoimmune diseases occur because of the body’s hyperactive immune response in relation to the tissues and substances normally present in the body. In autoimmune diseases, the body actually starts acting against itself. These disorders may be restricted to only a particular organ or tissue. Autoimmune diseases are treated with administration of medications which suppress the activity of the target organ –known as immunosuppression. The exact classification of autoimmune diseases is not possible. However, the overall domain of autoimmune diseases can be classified on indirect evidence based on generation of autoimmune disease in animals, direct evidence acquired from the transfer of antibody and circumstantial evidence.
Biopharmaceuticals are medical drugs which are produced with the help of biotechnology. The US is the largest market for biopharmaceuticals and is the leader in terms of revenue, by a substantial margin. The biopharmaceutical market can be classified based on the class of the medical drug into recombinant proteins, monoclonal antibodies and purified proteins. Based on the therapeutic applications, biopharmaceuticals can be classified as blood factors, thrombolytic agents, hormones, hematopoietic growth factors, interferon’s and vaccines.
Nutraceuticals are defined as the food and dietary substances which help lower the TC (total cholesterol) levels of the body. It functions by triggering the cholesterol inhibiting hormones of the body and thereby restoring homeostasis and preventing coronary heart diseases. Nutraceuticals are currently preferred more than general cholesterol lowering medications. The cholesterol lowering nutraceuticals ingredient market bears two major segmentations, on the basis of types into: beta glucans, soluble fibers, omega 3 fatty acids, plant sterols, soy foods and others, and on the basis of geography into: the North American, European, Asia Pacific and rest of the world regions.
Nutraceuticals have medicinal properties to treat or prevent diseases and they are food or parts of foods in the form of nutrients. Nutraceuticals foods have high antioxidant properties and are beneficial in fighting the causes of anti-aging. The free radicals produced by the body when cells in our body use oxygen, may cause oxidative damage to the body. Thus, these nutraceuticals help in preventing the side effects of those free radicals. Moreover, the human nature to remain young always has made popular the anti-aging medicines in the market. The rising disposable incomes and health awareness among people are expected to boost the anti-aging market in the near future.
Autologous cell therapy is a therapeutic procedure which uses the cells of an individual, which are well-bred and nurtured outside the body and then reintroduced at the site of the disease of the individual. Autologous cell therapy is a new breakthrough in the field of medical history. Autologous cell therapy (ACT) is one of the most rapidly evolving fields due to the revolution in the bioengineering sector since the last few decades.
Smart pill technology is used to diagnose gastro intestinal disorders such as constipation and gastroparesis. Smart pill technology functions by providing the practitioner with information pertaining to the GI (gastrointestinal) tract such as pH, temperature and pressure. The technology comprises of a wireless capsule, a receiver worn by the patient and the computer software which analyzes and sorts the information collated.
Biosimulation is computer aided mathematical simulation of biological systems and processes. Biosimulation is used for model based calculation of biological systems. The global biosimulation market is expected to grow at a considerable rate from 2011 to 2018.The primary reason for the growth of biosimulation is the increasing use of pharmacodynamic and pharmacokinetic (PKPD) modeling in pre-clinical drug development. PKPD is the most widely used method in drug development.
Digestive health enzymes market is witnessing upsurge demand in developed economies due to growing health concerns and rising standard of living. This market is set to witness double digit growth rate during the forecasted period. Demand for digestive health enzymes is also expected to grow in developing economies as people are becoming aware about the benefits of these enzymes and spending more on personal health.
Cancer biomarkers serve as an indicator of normal biological processes, pharmacologic response or pathogenic processes, to a therapeutic intervention. These biomarkers are used for prognosis, in order to predict the causes of a tumor. A doctor can also decide with the help of the biomarkers what dose might be most effective for the patients and which patient will respond positively to a given drug.As the area of drug development is facing new challenges and the cost of drug development is increasing, biomarkers are widely used by the pharmaceutical companies to overcome these challenges. Several new companies are emerging, in order to provide advanced technology platforms in different areas such as transcriptomics, genomics, metabolomics, bioinformatics and pharmacogenomics and this is serving as an important driver for the biomarkers market.
Among the several diseases worldwide, cancer is majorly responsible for a high global mortality rate. The number of cancer patients is soaring and in 2012 it is projected that 1,638,910 new cases of cancer will be found, whereas 577,190 people are projected to die from cancer. Of the several cancer types that exist, kidney cancer is projected to cause 12,484 deaths in 2012 and it is estimated that 59,588 new kidney cancer cases will emerge. Kidney cancer can be divided into two groups, i.e., renal pelvis cancer and renal parenchyma cancers.
Angina pectoris market is expected to grow at the CAGR of 3.5% and reach the value of $12,707.4 million by the year 2018. This growth is primarily driven by the increase in number of patients undergoing treatment for angina pectoris and likely approval of new therapies like varespladib and Generx that are in late stage of clinical development. If approved, these products are expected to contribute in the growth of angina pectoris industry as they will be marketed at premium price by their inventor companies. Innovative mechanism of action of these products will lead to improvements in effectiveness and safety over currently marketed products.
The wound care market is gaining traction worldwide, due to the increase in diseases caused by the change in lifestyle. People are more prone to diseases like diabetes, heart diseases and obesity. The number of population above forty is also increasing globally, Aged people are more prone to diseases when compared to the younger generation, thus driving the overall wound care market. The increase in number of new entrants in this market is increasing the competition across the globe.
Colorectal cancer is formed due to uncontrolled cell growth mainly in rectum, colon and appendix. The major reasons for colorectal cancer are aging population and changing lifestyle. People above 50 are more prone to colorectal cancer. It is the third most common type of cancer diagnosed across the world. More than 11 million people were diagnosed with cancer in 2008 and the number is set to rise in the coming years.
A biomarker is a gene, molecule or characteristics, by which pathogenic processes, biological processes or pharmacologic response can be evaluated or measured. They are classified on the basis of their application in different medical processes. These biomarkers help effectively in clinical decision making and thus help in diagnosing the health of a patient. In the present scenario, biomarkers are extensively used in the treatment of diseases such as cancer. The worldwide market of biomarkers is increasing tremendously due to its popularity and wide use in different drug discovery.
Medical education is the term associated with the practice of working as a medical practitioner either for initial training to become a doctor or for additional training after gaining the degree. Medical education market actors includemedical schools, health program providers, nursing programs providers, and such others. Continuous growth in world population and rising awareness towards personal health is creating the need for seeking medical education, either for working as a medical practitioner or for personal care.
Over the counter abbreviated commonly as OTC is practice of selling non prescription drugs or medication that can be sold without physician consultation. The drugs sold through OTC are “Active Pharmaceutical Ingredients (API)”. OTC drugs are proprietary mixtures formulated using single API or combination of APIs. There are more than 80 therapeutic classifications that are allowed to sale products through OTC. These categories range from analgesics, antipyretics to aphrodisiacs.
Impotency and urinary incontinence are growing concerns among people these days. Technological development is helping to overcome these age-related problems. There are various genitourinary drugs available today to cure the related illnesses. The genitourinary drugs market is expected to grow in developing economies in the near future due to growing concerns about urinary incontinence and related illnesses. The U.S. market remains the largest market for genitourinary drugs, while Japan stands in the second place in the consumption of genitourinary drugs.
Biometrics is the process of identification through the utilization of unique bodily functions such as DNA, finger prints and facial traits. The main function of such a system is to apprehend security threats. The healthcare biometrics market deals with the integration of the biometric process into the healthcare sector. The global healthcare biometrics market is expected to grow at a CAGR of 33% from 2012 to 2018, and it is expected to reach an estimated figure of USD 1,005.015 million by the year 2018. The U.S holds the maximum market share for the healthcare biometrics market and is also expected to grow at a steady growth rate.
Hormone replacement therapy (HRT) is administration of hormones to those patients who are under a phase of declining natural hormones in their body. Hormone replacement therapy is mostly administered to women undergoing menopausal phase. The hormones which are administered to patients are mostly Estrogen also supplemented by progesterone and testosterone. The modes of administration are oral tablets, implants, patches, vaginal creams etc. The global hormone replacement therapy market is expected to rise to approximately USD 3.6 billion by 2018.
Globally, the Non-Small-Cell Lung Cancer (NSCLC) drug market will increase from USD 4.3 billion in 2009 to USD 6.9 billion in 2019 and the market is growing with a CAGR of 4.84% during 2009 to 2019. The major markets in these segments are the United States, France, Germany, Italy, Spain, United Kingdom and Japan. The global top five global brands in NSCLC with the largest market share are Avastin, Tarceva, Alimta, Gemzar and Taxotere. For growth in the future there are drugs in the pipeline and in clinical trials at the phase 3 process development in the non small cell lung cancer market. In the year 2012 many pipeline agents are going to be launched - such as Stimuvax and Aflibercept. The drugs that are in clinical trials phase 3 processes are vargatef (BIBF 1120), BIBW 2992, Crizotinib, Erbitux, ARQ 197, and Ramucirumab.
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, immature blood cells are present in the bone marrow. Symptoms found in patients due to the disease are flu, loss of weight, body ache and pain and spots on skin. The Acute Myeloid Leukemia (AML) therapeutics market was USD 239.3 million in 2011 and this market is forecasted to reach USD 731.1 million in 2018.
This research is specially designed testimate and analyze the demand and performance of the health and wellness market in Russia, Ukraine and Kazakhstan. The report covers all the major segments of nutraceutical and cosmoceutical tidentify, analyze and provide in-depth analysis, market revenue, trend analysis and statistically refined forecast for the following segments covered.
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibiotic resistance problem are also expected to drive the antibiotics market. The demand for antibiotics is expected to reach USD 44.68 billion by 2016. Since, 2005 this market is seen to grow at an annual rate of 6.6% until 2011. There are many companies manufacturing antibiotic these days and there are many other antibiotics present in the market such as aminoglycoside antibiotics and it covers about 79% of the global demand.
Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, commercial biobanks, private cord banking, academic collections and other services such as DNA and RNA storage. The global biobanks market was USD 142.million in 2011 and it is forecasted that this market will reach USD 216.3 million in 2018 with the compound annual growth rate of 5.4 % from 2011 – 2018.
Next generation sequencers are associated with DNA sequencing, including several technologies which are used to determine the order of nucleotide bases in a DNA molecule. In the genomics space, it is estimated to be the most lucrative and fastest growing segment. The next generation sequencers market is expected to grow in double digits and it will bring in a new revolution in the field of biopharma, applied markets and academic laboratories. It can be even used in those laboratories where no sequencing techniques were used previously. The ongoing research is likely to boost the next generation sequencers market in the near future. This market is highly innovative and dynamic - the main factors responsible for driving the market at a high rate.
The global physician dispensed cosmeceuticals market was USD 560 million in 2011 and this market is projected to reach USD1.8 billion by 2018. The market will grow with the compound annual growth rate of 18.15% from 2011 – 2918. Physician dispensed cosmeceuticals market is categorised into product segments such as skin care and eyelash products. The demand for this market will spur due to factors such as product innovations, rise in surgical procedures, increase in consumer spending and growing number of dispensing physicians. In the current scenario, the market demand for dispensing physician’s cosmeceuticals is on a surge.
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal anti-inflammatory drugs. Although COX-2 is used in treatment of RA, it has several side effects associated with the upper gastrointestinal region. Currently, use of disease modifying antirheumatic drugs is recommended by most professionals in the early stages of disease.
SNP (single nucleotide polymorphism) analysis is the most common type of genetic variation between human beings and can be ideal for identifying the correlation between genotype and behavior of living organisms. Due to this reason, SNP analysis represents one of many pathways to personalized medicine. SNP analysis is used in different fields for specialized purposes; however, diagnostics and pharmacogenomics are the most promising applications of single nucleotide polymorphism.SNP genotyping can only analyze the variants that are provided on chips. Despite recent technological challenges faced by this industry, there is still strong growth potential and money in this market. The need to find rare genotype variants will require new chips and more samples which are resulting in greater use of machines and chemicals in the analysis process.
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those in later stage of development. The vaccines market has become high revenue generators despite being priced at a premium because of increasing occurrences of acute diseases and growing elderly population. The vaccine market has captured the attention of big pharmaceutical companies that have been watching the progress of this market.
The global orthobiological products market is expected to grow to $15.3 billion by the year 2022 as a result of tremendous growth in the medical devices industry mainly due to increase in aging population. Growth of orthobiological products is driven by increasing awareness towards adoption of orthobiologics, development in technology, and increasing number of orthopedic related procedures. As population continues to grow, there is simultaneous rise in aging population which is contributing to the growth of the orthobiological products industry as need for orthopedic procedures is greater in such elderly population. Other factors driving the growth of this market include increasing number of obese patients with rising levels of osteoarthritis and rheumatoid arthritis and patients with need for cartilage repair procedures.
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These gene amplification technologies are used for variety of applications in research and clinical settings. Currently, the market for gene amplification technologies is forecast to increase to $2.2 billion over the year 2017. This growth is expected to be driven by successful completion of human genome projects that will continue to boost the growth of this industry in future owing to the development of molecular diagnostics. Need for information about genes in genomics and other research progresses, and development in clinical diagnostic tools, is also expected to boost the growth of the gene amplification technologies market.
DNA sequencing industry is segmented into instruments and consumables, services, and workflow products. Instruments and consumables segment are the rapidly emerging segments accounting for about $2.2 billion by the year 2016. Services segment is expected to grow significantly and reach market value of $3.5 billion with CAGR of 29% over the year 2016. The workflow segment will reach $883.6 million at CAGR of 16.6% by 2016. The chain terminator DNA sequencing market and next generation DNA sequencing market are constantly undergoing technological changes, thus creating new opportunities and attracting new market players to this industry.
The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development. Also, developments in epigenetic studies like biomarker discovery and scientifically useful biomarker tests are expected to support the market growth. Epigenetics is a rapidly growing field of the biological science industry and biological researchers are progressively attempting to discover the process of cells exploiting the information programmed in genomes. It is the study of regulation of mechanisms other than DNA sequence over the genomic information programmed in DNA sequence. Recent discoveries and developments in this field are expected to bring about major revolution in healthcare industry and treatment of diseases in the long term.
Regenerative medicine industry is assumed to be the next generation technology to revolutionize the medical system in the upcoming years. This industry is still in growing stage in terms of commercial applications, with a number of available products being limited to the field of orthopedics. A majority of products in other therapeutic fields are in preclinical or early clinical assessment stage. Support from governments around the world and technological breakthroughs are expected to drive the market growth for the regenerative medicines industry.
The constant pressure to reduce healthcare spending is resulting in an increased focus on clinical laboratory services, making it the most valuable element in treatment plans. As hospital stays and contact between patient and physicians is reduced, clinical laboratory services are the only way to gather, interpret, and deliver appropriate information to physicians. This is resulting in the set up of increasing number of clinical labs, especially in independent sectors.
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coalitions and agreements to develop effective treatment on hepatitis C virus. In future, the growth of HCV market is expected to come from emerging markets of Asia Pacific, Middle East, and Latin America as these regions are likely to register maximum number of HCV incidences due to increasing HCV drug addicts.
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices are likely to emerge as safe, affordable, and accessible source of prescription drugs in the near future. The present scenario reflects higher penetration of the ePharmacy industry in developed countries as compared to the developing market. This is mainly because of the increasing use of Internet in developed economies.
The US market for personalized medicines is predicted to grow at the compounded annual growth rate of 9.5% during 2010 to 2015. This growth in future is expected to be driven by different factors like cost savings on treatments, early diagnosis of disease, drug safety, patient compliance, and optimization of therapies. Currently, America dominates the market for personalized medicine; however, advancement in technology and developments in the field of DNA is expected to establish personalized medicines market in UK, France, India, China, and Japan.
The increasing number of road mishaps mainly due to drunk driving is giving rise to the use of breath alcohol testing equipments like breath analyzers. Breath Analyzers are mainly used by transportation companies, whereas manufacturing and construction companies are also implementing on-site breath alcohol testing procedures. Demand for effective detection of alcohol impairment or blood alcohol content (BAC) level in individuals at workplaces is increasing.
The cancer diagnostics market is on the verge of sudden increase due to the technological breakthroughs in tumor diagnosis and unlocking of mysteries of genetics. The HPV (Human Papilloma Virus) testing market is expected to witness a promising growth in the next few years due to rising incidences of cancerous tumors and the growing ageing population.
Some of the factors driving neurometabolic disorders market are rising incidences of neurometabolic disorders and growing ageing population. Launch of new drugs coupled with the rising awareness among patients and physicians are expected to increase revenues for the neurometabolic disorders industry in the coming years.
Cancer is affecting about more than 10 million people every year globally and this number is expected to increase by 2.4% by the year 2020 and reach to 14 million. Biotherapy is one of the most promising and new approach in treatment of cancer as it enhances the natural tendency of body to defend itself against malignant tumors without damaging healthy tissues.
The biopharmaceutical industry is focusing on the growing complexity of licensing deals in order to secure marketing and commercialization rights within partnership deals. The major challenge faced by the biopharmaceutical licensing market is asymmetry between licensor and licensees.
The global pancreatic cancer drug market is projected to reach USD 1.2 billion by 2015. Among all the regions, the United States has recorded the maximum number of pancreatic cancer cases, which are about 30,000 patients each year. The survival rate is less than 5 years which acts as a major hurdle for the growth of this market.
High growth rate in emerging markets, technological advancements, strong support from governments and other active associations like WHO and GAVI, and increased investment in research and development are all leading to the overall growth of the vaccine production market. The vaccine production market is expected to exhibit improved performance in the coming years due to the successful launch of new vaccines.
There has been an increase in the disposable income in many countries across the globe. Also, the desire of each individual to maintain a youthful appearance has risen.
The oral care product market is growing rapidly due to technological advancements and introduction of fresh products in the market. Dentifrice and toothbrush are mainly responsible for the primary growth of this market. Rise in consciousness about maintaining oral care is likely to increase the growth rate in the near future. There are a variety of oral care products available in market manufactured by different companies.
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global biologics market is estimated to reach $176.4 billion by the end of 2012 and expected to grow at an annual compound growth rate of more than 9.5%.
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of these life saving drugs.
Influenza Vaccine is also called as flu shot and is used for protection against influenza virus. An influenza vaccine is a combination of three influenza viruses namely, influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain and influenza type B virus strain.
Diseases which cause improper functioning of liver are termed as Liver diseases. There are about hundreds of different known forms of liver diseases that ultimately lead to a condition named cirrhosis of liver which causes permanent damage of liver cells.
The women health therapeutics market is growing rapidly due to increasing awareness among patients & physicians and introduction of new therapies in the market. The women health therapeutics market was USD 14,530 million in 2010 and is expected to reach at USD 24,669 million by 2017 at an estimated CAGR of 7.9% during 2010-2017.
The global Veterinary Vaccines market is expected to reach USD 5.6 billion by 2015. Among all the geographies, Europe region is leading Veterinary vaccine market in terms of consumption, closely followed by the U.S.
Our research consists of both secondary and primary research with later constituting the greater portion. We also have a large internal repository and access to a number of external proprietary databases to help address specific requirements of our clients. The research process begins with exhaustive secondary research on internal and external sources being carried out to source qualitative and quantitative information relating to each market.
The report contains the global scenario of Vaccine market discussing its details and market figures. The report provides market size and forecast till 2016 for each segment and geography across the globe. It also describes the key influencing factors for the global vaccine market. The report lists mergers & acquisitions among the major players along with key product developments in the market. The report also provides information about major players in the market as company profiles.
Hepatitis B is caused by Hepatitis B Virus leading to inflammatory illness of liver. The disease has majorly affected various parts in Asia and Africa. The virus is majorly transmitted from exposure to infectious blood. There are numerous drugs available in the market, but none of them is effective in stopping the infection, they only help in slowing down the process of liver infection and thus minimize liver damage. The Market for hepatitis B vaccine is gaining traction in most parts of Asia and Africa.
Application of DNA Gene Chip technology are seen in gene expression profiling, comparative genomic hybridization, geneID and many more areas of medicinal research. It is extremely useful in medical research and drug discovery process as it is reducing the time taken for research.
Wound care products are used by medical practitioners to protect patients fragile skin, managing chronic & acute wounds and I.V. sites, wound closures, dressing and infections prevention.
Advances in the medical dressings and wound care have improved the ability of health professionals in the treatment of acute and chronic wounds. These products find applications for various hospital departments and procedures like operation theatres, intensive critical care units, emergency care and trauma care. Globally governments spending on health care is the main driver in this market.
Wound treatment market focuses on products such as dressings, closure devices, debridement, pharmacological products, tissue engineered products and others.
Ovarian cancer one of the most common cancer among women. Ovarian cancer is rarely diagnosed in the early stages. It is usually quite advanced by the time diagnosis is made. Older women are at highest risk for developing ovarian cancer. Most deaths from ovarian cancer occur in women age 55 and older. Surgery is used in treatment of all stages of ovarian cancer.
Worldwide more than one million new cases of breast cancer are found every year. Breast cancer can spread to the bone, followed by the lung and liver. Metastatic breast cancer is the most advanced stage of the breast cancer. The key drivers of breast cancer treatment market are aging population, obesity and family history among others. Breast cancer is usually found in women over the age of 40 years. For treatment of breast cancer, surgery is used first and then drugs or radiation therapy or both are used. North America, Europe have witnessed largest rate of breast cancers in women.
G protein coupled receptors which are also known by other names such as heptahelical receptors, G protein-linked receptors (GPLR), serpentine receptor and 7TM receptors comprises of a large family of protein. They are found in eukaryotes and choanoflagellates. GPCRs are targeted by approximately 45% to 50% of medicinal drugs. The major factors which are driving the growth of the GPCRs market include: growing researcher interest in targeting GPCR for medicinal drugs, development in indentifying new membrane structure and newer structures and the advancement in technologies used.
Human immuno deficiency virus causes continuous failure of immune systems leading to death. HIV virus was discovered in 1981 and has killed more than 35 million people till date. Majority of the HIV infected population lives in sub Saharan Africa. HIV infections are caused during transfer of blood, unsafe sex, vaginal fluid, infected needles and several other reasons.
Biosimilars or follow-on biologics are copies of biological drugs (biopharmaceuticals). Biosimilars provide significant cost saving to both the users and the industry hence the adoption of these drugs are expected to be higher side. However, the debate on the interest of original biopharmaceutical developer and stability of copied drug has raised controversies across the globe.
Meanwhile low entry barriers and absence of clear regulatory norms for biological drugs and non-approval of follow-on biologics in the U.S. market; has prompted pharmaceutical companies to turn towards emerging markets such as India and countries in the South-East Asia.
The need to stay fit and agile has led to an increase in the number of gymnasiums and other weight loss facilities across the globe, thus driving the market for weight management products. Among the two methods of weight loss dieting and physical exercise, latter is considered more effective and sustainable. United States accounts for the maximum number of obese people worldwide. Obesity is increasing like a epidemic across the globe, thus driving the need for weight management products globally.
Stem cells are biological cells capable of dividing and self renewing in order to produce more stem cells. The regulatory acceptance of this technology is one of the major forces driving the market, whereas the high cost of therapy might hamper the growth of the stem cells market. Among all the geographies United States holds approximately 60% of the stem cell market followed by Europe and Asia Pacific.
Enzyme inhibitors are used as drugs for treating diseases and are commonly found in nature. They are molecules which decreases the activity of enzymes by binding with them. They are also used as pesticides and herbicides and can also cure metabolic imbalance. There are two types of enzyme inhibitors reversible and irreversible.
RNAi stands for Ribonucleic Acid Interference; it is a process that keeps a check on active genes by moderating their activity. The market for RNAi Technology will gain traction due to its applicability in various fields such as drug discovery, agriculture, therapeutics and others. RNAi Technology is classified as micro RNA and Small interfering RNA.
Dietary Supplements are intended to provide vitamins, minerals, nutrition, fibers and amino acids that are lacking or are in insufficient quantity in a person’s diet. One of the major factors contributing to the growth of the market is the increase in population ranging between 18 to 29 years globally.
Pharmaceutical Research
The Pharmaceutical Industry is a key segment for global economical growth. While the industry is dominated by developed countries mainly US, the developing countries like China and India shows an impressive growth in recent years. There is significant increase in the demand for innovative drugs which drives R&D investment in the industry across various countries. The biopharmaceuticals has brought revolutionary change for new drug inception. Proteomics, Molecular biology and Genomics have helped the manufacturers to to innovate effective drugs & processes for formulation.
The major factors affecting the growth of the industry are regulation & reforms, pricing issues. The major MNCs are nowadays outsourcing the R&D to reduce the cost and leverage the skill work pool across the countries.
The sector covers wide range of large MNCs, mid-size firms, specialty drug maker organization, generic manufactures, and biopharmaceutical firms, small scale industries, various support facility, contract research by service companies, contract sales, regulatory guidance, etc.
What people
are saying
Thank you for making sure I had this report on time with appropriate market numbers. I truly appreciate your timely delivery Fortune 500 Chemical Company (privacy requested)
